Phase I dendritic cell p53 peptide vaccine for head and neck cancer.
Schuler PJ, Harasymczuk M, Visus C, Deleo A, Trivedi S, Lei Y, Argiris A, Gooding W, Butterfield LH, Whiteside TL, Ferris RL.
Schuler PJ, et al. Among authors: ferris rl.
Clin Cancer Res. 2014 May 1;20(9):2433-44. doi: 10.1158/1078-0432.CCR-13-2617. Epub 2014 Feb 28.
Clin Cancer Res. 2014.
PMID: 24583792
Free PMC article.
Clinical Trial.